Rossmore Private Capital’s AstraZeneca AZN Stock Holding History

Rossmore Private Capital’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.52M	Buy	33,683 +487	+1%	+$93.9K	0.57%	41
2025 Q4	$6.1M	Buy	33,196 +896	+3%	+$157K	0.54%	44
2025 Q3	$4.96M	Buy	32,300 +183	+0.6%	+$27.7K	0.53%	44
2025 Q2	$4.49M	Buy	32,117 +927	+3%	+$130K	0.52%	48
2025 Q1	$4.58M	Buy	31,190 +1,277	+4%	+$185K	0.56%	45
2024 Q4	$3.99M	Hold	29,913	–	–	0.49%	50
2024 Q3	$4.66M	Sell	29,913 -252	-0.8%	-$40.7K	0.58%	45
2024 Q2	$4.71M	Buy	30,165 +7,835	+35%	+$1.18M	0.62%	41
2024 Q1	$3.03M	Buy	+22,330	New	+$2.96M	0.4%	55
2018 Q1	–	Sell	-205	Closed	-$14.2K	–	120
2017 Q4	$14.2K	Buy	+205	New	+$13.8K	0.01%	275

Other funds holding AZN

Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VAM

Vanguard Asset Management London, Ec4n 8af $117B AUM

Rossmore Private Capital's AZN Position: Q1 2026 in Review

Rossmore Private Capital increased its AstraZeneca (AZN) stake by 1.5% in Q1 2026, buying an estimated $93.9K and bringing the position to 33,683 shares worth $6.52M. The position accounts for 0.57% of the portfolio, ranked #41.

Rossmore Private Capital first reported a position in AZN in Q4 2017 and has held it in 10 quarters since. 1,379 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

Rossmore Private Capital held 33,683 shares of AstraZeneca worth $6.52M as of Q1 2026.
Rossmore Private Capital bought 487 AstraZeneca shares in Q1 2026, an estimated $93.9K.
AstraZeneca made up 0.57% of Rossmore Private Capital's portfolio in Q1 2026, its #41 holding.
Rossmore Private Capital first reported a position in AstraZeneca in Q4 2017 and has held it in 10 quarters since.
1,379 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Rossmore Private Capital's 13F filing for Q1 2026, filed 1 May 2026.